APOC3 and metabolic dysfunction-associated steatotic liver disease: The major findings of this study indicate that the ApoC-III gene polymorphisms rs2854116 and rs2854117 are not significantly associated with the presence or severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in our Turkish population.